Abstract
Amyloid beta peptide (Aβ) is recognised as a main feature of Alzheimer’s disease (AD). Increasing evidence suggests that small soluble oligomers of Aβ are the toxic form of the peptide and may instigate AD. Different factors including some key residues within Aβ molecule, the cell membrane, prion protein and metals play important roles in developing AD. Significant progress has been made to understand these factors and elucidate the mechanism of cytotoxicity of Aβ. This review summarizes recent findings in the area of Aβ and AD research, and this current knowledge could enable medicinal chemists to design and develop therapeutics to treat AD.
Keywords: Amyloid beta peptide, Alzheimer’s disease, oligomers, cytotoxicity, prion protein, metal interactions.
Current Medicinal Chemistry
Title:Amyloid Beta (Aβ) Peptide and Factors that Play Important Roles in Alzheimer’s Disease
Volume: 23 Issue: 9
Author(s): Elaheh Jamasbi, John D. Wade, Frances Separovic and Mohammed A. Hossain
Affiliation:
Keywords: Amyloid beta peptide, Alzheimer’s disease, oligomers, cytotoxicity, prion protein, metal interactions.
Abstract: Amyloid beta peptide (Aβ) is recognised as a main feature of Alzheimer’s disease (AD). Increasing evidence suggests that small soluble oligomers of Aβ are the toxic form of the peptide and may instigate AD. Different factors including some key residues within Aβ molecule, the cell membrane, prion protein and metals play important roles in developing AD. Significant progress has been made to understand these factors and elucidate the mechanism of cytotoxicity of Aβ. This review summarizes recent findings in the area of Aβ and AD research, and this current knowledge could enable medicinal chemists to design and develop therapeutics to treat AD.
Export Options
About this article
Cite this article as:
Jamasbi Elaheh, Wade D. John, Separovic Frances and Hossain A. Mohammed, Amyloid Beta (Aβ) Peptide and Factors that Play Important Roles in Alzheimer’s Disease, Current Medicinal Chemistry 2016; 23 (9) . https://dx.doi.org/10.2174/0929867323666160229113911
DOI https://dx.doi.org/10.2174/0929867323666160229113911 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Discovery of α1-Adrenoceptor Agonists
Current Topics in Medicinal Chemistry Postprandial Glucose - A Potential Therapeutic Target to Reduce Cardiovascular Mortality
Current Vascular Pharmacology Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Prion Function and Pathophysiology in Non-Mammalian Models
Current Molecular Medicine Editorial (Hot Topic: Biomedical Engineering Imaging)
Current Pharmaceutical Biotechnology Homocysteine in Neurological Disease: A Marker or a Cause?
CNS & Neurological Disorders - Drug Targets ApoE ε4 Allele Related Alterations in Hippocampal Connectivity in Early Alzheimer’s Disease Support Memory Performance
Current Alzheimer Research “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease
Current Alzheimer Research White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Current Alzheimer Research Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Pin1: A New Genetic Link between Alzheimer’s Disease, Cancer and Aging
Current Aging Science Platelets and Vascular Risk: An Option for Treatment
Current Pharmaceutical Design Conference Report:5<sup>th</sup> International Conference on Nanotek & Expo, Nov 16-18, 2015, San Antonio TX, USA
CNS & Neurological Disorders - Drug Targets Development and Potential Utility of Dual and Triple NK Receptor Antagonists
Current Topics in Medicinal Chemistry Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Transendothelial Migration of Monocytes: The Underlying Molecular Mechanisms and Consequences of HIV-1 Infection
Current HIV Research Cell Cycle Re-Entry in Alzheimers Disease: A Major Neuropathological Characteristic?
Current Alzheimer Research Clinical Applications of MAO-Inhibitors
Current Medicinal Chemistry Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers
Current Psychiatry Reviews